News

The operator of the Fukushima Daiichi nuclear power plant has submitted a plan to demolish a building next to the No. 3 ...
Step into the historic Daiichi Takimotokan, Hokkaido’s premier onsen resort since 1858. Located beside Noboribetsu’s Hell Valley, this ryokan boasts 35 baths sourced from five distinct hot springs, ...
AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat a type of lung cancer, marking the first approval of the therapy in this ...
Researchers who conducted a real-world analysis of trastuzumab deruxtecan found the drug to be effective in treating metastatic breast cancer, though survival outcomes did not reach clinical trial ...
Decontaminated but slightly radioactive soil from Fukushima has been delivered to the Japanese prime minister’s office to be ...
Fukushima Daiichi, the decommissioned power plant, is like no place I've ever been. James Martin/CNET Each day, thousands of workers struggle to clean up the disabled 860-acre site.
The Association of the British Pharmaceutical Industry (ABPI) has appointed Laura McMullin as vice president of the trade ...
The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a Phase 2 trial. The approval was also supported by data from a Phase 3 trial ...
Daiichi Sankyo has announced the first subject dosing in the Phase III DESTINYEndometrial01 trial of Enhertu (trastuzumab deruxtecan) plus rilvegostomig or pembrolizumab versus platinum-based ...
MADRID—Daiichi Sankyo and ADC partner AstraZeneca finally have some clarity on the deaths that occurred in a pair of phase 3 studies for their Enhertu follow up Dato-DXd. ...
Merck and Daiichi Sankyo agreed to jointly develop and commercialize three potential cancer treatments in a deal worth up to $22 billion. Merck and Daiichi Sankyo will develop and commercialize ...